A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Summary

The purpose of this research study is to evaluate safety, pharmacokinetics and preliminary efficacy of the investigational drug PLX73086 in subjects with solid tumors including subjects with locally advanced or refractory tenosynovial giant cell tumor (TGCT).

Timeline

Start

2016-02

Primary completion

2018-01

Completion

2018-01

Outcome

Outcome not reported

Stopped: “Discontinued”

Drugs

Indications